As shown in Figure 1B, the overall survival of patients with LBX2‐AS1 expression levels higher than the median value in their ovarian cancer tissue specimens was significantly lower than that of patients with LBX2‐AS1 expression levels lower than the median value. This evidence concerns the gene LBX2 and ovarian carcinoma.